Name: 5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference
Start: 2024-03-21
End: 2024-03-22
Location: Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH

WHAT TO EXPECT

Key Sessions on Molecular Diagnostics:

•   Developing a Molecular and Rapid Testing Diagnostic Service
•   The Impact of NGS in Diagnostic Virology Involving HIV-1 Tropism, Genotypic Resistance in Influenza, HBV, Hepatitis C Virus (HCV) and Cytomegalovirus (CMV)
•   Current Molecular Diagnostics and Whole Genome Sequencing (WGS) Applied to Mycobacteria
•   KCL TEST: Matching Results from the ONS and Generating Molecular Biology Laboratory-Based Protocols
•   Molecular Diagnosis of Drug-Resistant Tuberculosis

Key Sessions on Infectious Diseases:

•   Clinical Validation of a Point-of-Care Multiplexed In Vitro Immunoassay Using Monoclonal Antibodies
•   The Impact of Digital Technologies on Point-of-Care Diagnostics in Resource-Limited Settings.
•   The Challenges and Some Emerging Strategies for Tackling a Global Bacterial Menace
•   Biosensors for the Detection of Bacterial and Viral Clinical Pathogens
•   Electrochemical Diagnostics of Infectious Viral Diseases

Stay Updated: The conference provides a platform to gain insights into the latest advancements, trends, and innovations in infectious disease diagnostics and molecular diagnostics.

Networking Opportunities: With 120+ professionals attending the conference provides an excellent opportunity to network, forge valuable connections, and collaborate with like-minded individuals who share a passion for diagnostics and healthcare.

Knowledge Exchange: The conference features discussions, presentations, and interactive sessions led by industry experts and thought leaders.

Emerging Technologies: The conference focuses on trending technologies in diagnostics and their applications. By attending, you can gain insights into emerging tools, platforms, and methodologies that can enhance diagnostic accuracy, speed, and precision.

Address Challenges: The conference addresses challenges faced in the diagnostics field. By participating, you can learn about potential solutions and best practices to overcome these hurdles in the diagnostics world.

Global Healthcare Perspectives: The conference examines the need for improved healthcare worldwide and explores how diagnostics can contribute to this goal. You can gain a broader understanding of the global healthcare landscape and discover ways to facilitate better healthcare outcomes on a global scale.

Vaccine Insights: The event also covers topics related to vaccine efficacy, side effects, and their impact on diagnostics.

Hospitals/Universities/Labs

Hospitals - Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department, Molecular Biology, Molecular Genetics
Hospital Designations - Senior scientist, scientist, Microbiologist, biologists, pathologist, General
Practitioners, Lab managers, Lab directors, medical directors, POCT coordinators
Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors
Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Clinicians
Pharma/Therapeutics Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

CONFERENCE AGENDA

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening remarks from the Chairman Andrew Benson, Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc	08:55 - 09:00
ADAPTING MOLECULAR DIAGNOSTICS FOR EVOLVING DISEASES
Keynote Presentation -The Co-Dx PCR platform: the future of accessible diagnostics Dwight Egan, Chief Executive Officer, Co-Diagnostics, Inc	09:00 - 09:30
Developing a Molecular and Rapid Testing Diagnostic Service Stuart Whitmore, Molecular Laboratory Manager, East Suffolk and North Essex NHS Foundation Trust	09:30 - 10:00
Skip to the good bit - Prepyx® Extraction-Free Buffer Nicole Ball, Application Specialist (Molecular), R-Biopharm Rhône Ltd	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:20
The universal one workflow in PCR multiplex testing Jennifer Juwah, UK Business Manager - Molecular Biology, Eurobio Scientific UK	11:20 - 11:50
REDESIGNING DIAGNOSTICS WITH NEXT-GEN TECHNOLOGIES
Antimicrobial Resistance and Testing Helen Dent, CEO, BIVDA Helen Dent	11:50 - 12:20
The Devil is in the Data Eimear Malone, Molecular Product Specialist, Randox Laboratories	12:20 - 12:50
Lateral flow and molecular diagnostics - the best of both worlds Nina Garrett, Chief Technical Officer, Abingdon Health	12:50 - 13:20
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:20 - 14:20
Unlocking the Potential of CandID in the Diagnosis of Invasive Candidiasis Gemma Johnson, Scientific Director, OLM Diagnostics	14:20 - 14:50
SHAPING THE CUSTOMIZED MODEL’S AND ADVANCEMENTS IN POINT OF CARE TESTING FOR INFECTIOUS DISEASE DIAGNOSTICS
Rapid Diagnostic Workflow in the Sepsis Adriana Calderaro, Full Professor of Clinical Microbiology, University Hospital of Parma	14:50 - 15:20
Modern Tools for Rapid Diagnostics of Antimicrobial Resistance Dushyanthie Athukorala, Consultant in Microbiology, UHCW NHS Trust	15:20 - 15:50
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:50 - 16:30
ENCOURAGING DIAGNOSTIC TECHNIQUES IN THE ERA OF CONSOLIDATION
Blood Borne Virus Screen (BBV) testing in emergency departments – Pathology perspective Dipti Patel, Infection and Immunity Lead \| Scientist/Manager, Imperial College Healthcare NHS Trust	16:30 - 17:00
Reworking qPCR for extreme and point-of-care applications Demonstration of low denaturation, high polymerisation temperature qPCR Demonstration of extreme PCR completing 30 cycles in less than 2 minutes Stephen Bustin, Professor of Molecular Medicine, Medical Technology Research Centre, Anglia Ruskin University, UK	17:00 - 17:30
Closing Remarks from the Chairperson Andrew Benson, Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc	17:30 - 17:30
Drinks Reception & Networking End of Day 1	17:30 - 17:30

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening remarks from the Chairman Andrew Benson, Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc	08:55 - 09:00
FUTURE MOLECULAR DIAGNOSTICS AND NEW DIAGNOSTIC TECHNOLOGIES
Keynote Presentation: Accessible TB Diagnostics on the Co-Dx PCR Pro in LMICs Joseph Featherstone, Head of Business Development, Co-Diagnostics, Inc	09:00 - 09:30
Technological advances in Infectious Diseases diagnostics: New lamps for Old? Elfatih Mustafa Awadel-Kariem, Consultant Microbiologist & Director for Infection Prevention & Control (DIPC), Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust	09:30 - 10:00
Emerging Challenges in the Diagnosis of Azole-Resistant Invasive Aspergillosis Paul E. Verweij, Professor of Clinical Mycology, Radboud University Nijmegen Medical Center	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:20
Screening for Immunity to Support Vaccination Strategies Jennifer Heaney, Researcher, University of Birmingham	11:20 - 11:50
SHAPING THE POINT OF CARE ERA WITH BEST TOOLS AND METHODOLOGIES
Utility of Artificial Intelligence (AI) in management of infectious diseases Peter Munthali , Consultant- Bacteriology · Microbiology, University Hospital Coventry	11:50 - 12:20
Design and proof of principle in a mouse model of a promising vaccine for Zika virus that is currently in phase I clinical trial Thomas Blanchard, Consultant in Infectious Disease, Liverpool University Hospitals NHS Foundation Trust	12:20 - 12:50
Lunch and Poster Presentation \| One-to-One Networking Meetings	12:45 - 13:50
WGS as a Proactive Tool for Cutting Down Healthcare-Associated Transmission of Infections Susie Jerwood, Medical Microbiologist,	13:50 - 14:20
Panel Discussion: Virology Remains a Rapidly Changing Field and the Diagnostic Clinical Laboratory must keep Abreast of newer Viruses, Targets and Technologies Susie Jerwood, Medical Microbiologist, Stephen Bustin, Professor of Molecular Medicine, Medical Technology Research Centre, Anglia Ruskin University, UK Elfatih Mustafa Awadel-Kariem, Consultant Microbiologist & Director for Infection Prevention & Control (DIPC), Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust Thomas Blanchard, Consultant in Infectious Disease, Liverpool University Hospitals NHS Foundation Trust	14:20 - 15:00
Closing Remarks from the Chairperson Andrew Benson, Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc	15:00 - 15:00
End of Conference	15:00 - 15:00

SPEAKERS

Helen Dent

CEO, BIVDA Helen Dent

Nicole Ball

Application Specialist (Molecular), R-Biopharm Rhône Ltd

Andrew Benson

Chairperson, Head of Corporate Communications, Co-Diagnostics, Inc

Gemma Johnson

Scientific Director, OLM Diagnostics

Paul E. Verweij

Professor of Clinical Mycology, Radboud University Nijmegen Medical Center

Susie Jerwood

Medical Microbiologist,

Dipti Patel

Infection and Immunity Lead | Scientist/Manager, Imperial College Healthcare NHS Trust

Stephen Bustin

Professor of Molecular Medicine, Medical Technology Research Centre, Anglia Ruskin University, UK

Jennifer Heaney

Researcher, University of Birmingham

Dushyanthie Athukorala

Consultant in Microbiology, UHCW NHS Trust

Joseph Featherstone

Head of Business Development, Co-Diagnostics, Inc

Stuart Whitmore

Molecular Laboratory Manager, East Suffolk and North Essex NHS Foundation Trust

Peter Munthali

Consultant- Bacteriology · Microbiology, University Hospital Coventry

Elfatih Mustafa Awadel-Kariem

Consultant Microbiologist & Director for Infection Prevention & Control (DIPC), Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust